Abstract:Like other autoimmune diseases, rheumatoid arthritis (RA) develops in distinct stages, with each phase of disease linked to immune cell dysfunction. HLA class II genes confer the strongest genetic risk to develop RA. They encode for molecules essential in the activation and differentiation of T cells, placing T cells upstream in the immunopathology. In Phase 1 of the RA disease process, T cells lose a fundamental function, their ability to be self-tolerant, and provide help for autoantibody-producing B cells. Phase 2 begins many years later, when mis-differentiated T cells gain tissue-invasive effector functions, enter the joint, promote non-resolving inflammation, and give rise to clinically relevant arthritis. In Phase 3 of the RA disease process, abnormal innate immune functions are added to adaptive autoimmunity, converting synovial inflammation into a tissue-destructive process that erodes cartilage and bone. Emerging data have implicated metabolic mis-regulation as a fundamental pathogenic pathway in all phases of RA. Early in their life cycle, RA T cells fail to repair mitochondrial DNA, resulting in a malfunctioning metabolic machinery. Mitochondrial insufficiency is aggravated by the mis-trafficking of the energy sensor AMPK away from the lysosomal surface. The metabolic signature of RA T cells is characterized by the shunting of glucose toward the pentose phosphate pathway and toward biosynthetic activity. During the intermediate and terminal phase of RA-imposed tissue inflammation, tissue-residing macrophages, T cells, B cells and stromal cells are chronically activated and under high metabolic stress, creating a microenvironment poor in oxygen and glucose, but rich in metabolic intermediates, such as lactate. By sensing tissue lactate, synovial T cells lose their mobility and are trapped in the tissue niche. The linkage of defective DNA repair, misbalanced metabolic pathways, autoimmunity, and tissue inflammation in RA encourages metabolic interference as a novel treatment strategy during both the early stages of tolerance breakdown and the late stages of tissue inflammation. Defining and targeting metabolic abnormalities provides a new paradigm to treat, or even prevent, the cellular defects underlying autoimmune disease.

Deficient Activity of the Nuclease Mre11a Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis

The DNA Repair Nuclease MRE11A Functions As a Mitochondrial Protector and Prevents T Cell Pyroptosis and Tissue Inflammation

Immunosenescence of T cells: a key player in rheumatoid arthritis

Telomerase insufficiency in rheumatoid arthritis

Mechanisms of age-related Treg dysfunction in an arthritic environment

T-Cell Aging-Associated Phenotypes in Autoimmune Disease

Aging of the Immune System. Mechanisms and Therapeutic Targets

Aging-associated HELIOS deficiency in naive CD4+ T cells alters chromatin remodeling and promotes effector cell responses

Decreased Dna Methyltransferase Levels Contribute to Abnormal Gene Expression in "senescent" Cd4(+)Cd28(-) T Cells

Age-related self-DNA accumulation may accelerate arthritis in rats and in human rheumatoid arthritis

Transcription Factor Analysis to Investigate Immunosenescence in Rheumatoid Arthritis Patients

The role of cellular senescence in the pathogenesis of Rheumatoid Arthritis: Focus on IL-6 as a target gene

Impaired Tip60-mediated Foxp3 Acetylation Attenuates Regulatory T Cell Development in Rheumatoid Arthritis.

YTHDC1 Regulates the Migration, Invasion, Proliferation, and Apoptosis of Rheumatoid Fibroblast-Like Synoviocytes

Th1 biased progressive autoimmunity in aged Aire-deficient mice accelerated thymic epithelial cell senescence

Restoring Oxidant Signaling Suppresses Proarthritogenic T Cell Effector Functions in Rheumatoid Arthritis.

Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis

Metabolic Signatures of T-cells and Macrophages in Rheumatoid Arthritis.

mutations limit normal and autoreactive Tfh differentiation

T-cell metabolism in rheumatoid arthritis: focus on mitochondrial and lysosomal dysfunction

Human T cell immunosenescence and inflammation in aging